Zosano Pharma Corporation / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €672.03K +250.4% -€25.78M -9.8% -3,836.2% +110 pp -€18.98M -4.6% -2,823.8% +75 pp
    €191.76K +∞% -€28.57M -11.2% -14,896.9% -150 pp -€19.89M +0.8% -10,371.0% -100 pp
    €0.00 +NaN% -€32.18M +6.3% N/A -€19.74M -2.4% N/A
    €0.00 +NaN% -€30.27M +21.5% N/A -€20.23M -8.7% N/A
    €0.00 +NaN% -€24.92M -2.4% N/A -€22.15M +1.9% N/A
    €0.00 -100.0% -€25.54M +4.9% N/A -€21.74M +7.1% N/A
    €267.96K -89.1% -€24.34M +99.6% -9,082.1% -86 pp -€20.31M +143.6% -7,579.2% -72 pp
    €2.45M -32.7% -€12.19M +153.9% -497.8% -3.7 pp -€8.34M +244.5% -340.4% -2.7 pp
    €3.64M -63.4% -€4.80M -408.5% -132.0% -1.5 pp -€2.42M -641.6% -66.5% -0.71 pp
    €9.95M €1.56M 15.6% €446.88K 4.5%

    Notifications